Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Mar 29:7:18.
doi: 10.1186/1471-2156-7-18.

Spontaneous rescue from cystic fibrosis in a mouse model

Affiliations

Spontaneous rescue from cystic fibrosis in a mouse model

Nikoletta Charizopoulou et al. BMC Genet. .

Abstract

Background: From the original CftrTgH(neoim)Hgu mutant mouse model with a divergent genetic background (129P2, C57BL/6, MF1) we have generated two inbred CftrTgH(neoim)Hgu mutant strains named CF/1-CftrTgH(neoim)Hgu and CF/3-CftrTgH(neoim)Hgu, which are fertile and show normal growth and lifespan. Initial genome wide scan analysis with microsatellite markers indicated that the two inbred strains differed on the genetic level. In order to further investigate whether these genetic differences have an impact on the disease phenotype of cystic fibrosis we characterised the phenotype of the two inbred strains.

Results: Reduced amounts, compared to wild type control animals, of correctly spliced Cftr mRNA were detected in the nasal epithelia, lungs and the intestine of both inbred CftrTgH(neoim)Hgu strains, with higher residual amount observed for CF/1-CftrTgH(neoim)Hgu than CF/3-CftrTgH(neoim)Hgu for every investigated tissue. Accordingly the amounts of wild type Cftr protein in the intestine were 9% for CF/1-CftrTgH(neoim)Hgu and 4% for CF/3-CftrTgH(neoim)Hgu. Unlike the apparent strain and/or tissue specific regulation of Cftr mRNA splicing, short circuit current measurements in the respiratory and intestinal epithelium revealed that both strains have ameliorated the basic defect of cystic fibrosis with a presentation of a normal electrophysiology in both tissues.

Conclusion: Unlike the outbred CftrTgH(neoim)Hgu insertional mouse model, which displayed the electrophysiological defect in the gastrointestinal and respiratory tracts characteristic of cystic fibrosis, both inbred CftrTgH(neoim)Hgu strains have ameliorated the electrophysiological defect. On the basis of these findings both CF/1-CftrTgH(neoim)Hgu and CF/3-CftrTgH(neoim)Hgu offer an excellent model whereby determination of the minimal levels of protein required for the restoration of the basic defect of cystic fibrosis can be studied, along with the modulating factors which may affect this outcome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Quantification of wild type Cftr protein in apical membranes (only band C present) of enterocytes of F28 CF/1-CftrTgH(neoim)Hgu (n = 4) and F27 CF/3-CftrTgH(neoim)Hgu (n = 4) mutant mice. Blots were labelled using the Cftr specific R3195 antibody.
Figure 2
Figure 2
Alcian blue staining of deparaffinised sections of jejunum (A, B, C, magnification ×200) and ileum (D, E, F, magnification ×400) from wild type MF1 (A, D) and mutant F28 CF/1-CftrTgH(neoim)Hgu (B, E) and F27 CF/3-CftrTgH(neoim)Hgu (C, F) animals showed focal hypertrophy of goblet cells in the ileum of the two inbred CftrTgH(neoim)Hgu mutant mice. Goblet cell counts are given as percentage of all epithelial cells. From each strain two mice and three sections/mouse were counted. Goblet cell count: CF/1 = 22.7% ± 2.3 (p = 0.112, p-value CF/1 compared to MF1), CF/3 = 23% ± 2.8 (p = 0.172, p-value CF/3 compared to MF1), MF1 = 16.8% ± 1.2. The jejunal sections of the same mice did not show any signs of goblet cell hypertrophy and were similar to wild type MF1 (Goblet cell count: CF/1 = 7.4% ± 0.4 (p = 0.18, p-value CF/1 compared to MF1), CF/3 = 8.5% ± 1.2 (p = 0.77, p-value CF/3 compared to MF1), MF1 = 8.8% ± 0.7.
Figure 3
Figure 3
Immunohistological analysis of CftrTgH(neoim)Hgu Cftr expression. Immunocytochemical staining of Cftr in the duodenum, jejunum, ileum of wild type mice MF1 (A, B, C), duodenum (E, magnification ×200), jejunum (F, magnification ×200) and ileum (G, magnification ×400) of homozygous F28 CF/1-CftrTgH(neoim)Hgu and duodenum (H, magnification ×200), jejunum (I, magnification ×200) and ileum (J, magnification ×400) of F27 CF/3-CftrTgH(neoim)Hgu mice was performed with the R3195 anti-Cftr antibody as described in Methods. Wild type mice showed intense Cftr staining of the apical border of epithelial cells. In CF/1-CftrTgH(neoim)Hgu and CF/3-CftrTgH(neoim)Hgu mutant mice Cftr staining was weaker and more diffuse mainly in the upper villus region. Ileum of a CF-Knock out mouse (D) was used as negative control.
Figure 4
Figure 4
Cftr immunostaining in the nasal epithelium of wild type MF1 (A, magnification ×400), C57BL/6J (B, ×400), F30 CF/1-CftrTgH(neoim)Hgu (C ×400), F29 CF/3-CftrTgH(neoim)Hgu (D, ×400).
Figure 5
Figure 5
Short-circuit current (Isc) measurements. delta Isc represents the change in short-circuit current from baseline after addition of either forskolin, genistein, carbachol, or amiloride. Upper panel. Bioelectric characteristics of the F28 CF/1-CftrTgH(neoim)Hgu (n = 4) and F27 CF/3-CftrTgH(neoim)Hgu (n = 4) in the ileum compared with those of wild type MF1 (n = 5) and C57BL/6J (n = 4) mice. *, significant p-values compared to MF-1. Lower panel. Bioelectric characteristics of the F28 CF/1-CftrTgH(neoim)Hgu and F27 CF/3-CftrTgH(neoim)Hgu in the nasal epithelium compared with those of wild type MF1 and C57BL/6J. The amiloride response is significantly increased in both CF/1-CftrTgH(neoim)Hgu and CF/3-CftrTgH(neoim)Hgu mice compared to MF1 wild type outbred mice. C57BL/6J inbred wild type mice exhibited less chloride secretion than MF1. The forskolin evoked chloride secretion in both CF/1-CftrTgH(neoim)Hgu CftrTgH(neoim)Hgu and CF/3-CftrTgH(neoim)Hgu was reduced compared to wild type MF1 but elevated compared to wild type C57BL/6J inbred mice.

Similar articles

Cited by

References

    1. Riordan J, Rommens J, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J, Drumm M, Iannuzzi M, Collins F, Tsui LC. Identification of the cystic fibrosis gene: cloning and characterisation of complementary DNA. Science. 1989;245:1066–1073. - PubMed
    1. Dorin JR, Dickinson P, Alton EWFW, Smith N, Geddes DM, Stevenson BJ, Kimber WL, Fleming S, Clarke AR, Hooper ML, Anderson L, Beddington RSP, Porteous DJ. Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature. 1992;359:211–215. doi: 10.1038/359211a0. - DOI - PubMed
    1. Dorin JR, Stevenson BJ, Fleming S, Alton EWFW, Dickinson P, Porteous DJ. Long term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type Cftr gene expression. Mamm Genome. 1994;5:465–472. doi: 10.1007/BF00369314. - DOI - PubMed
    1. Chiba-Falek O, Parad RB, Kerem E, Kerem B. Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation. Am J Respir Crit Care Med. 1999;159:1998–2002. - PubMed
    1. Ramalho AS, Beck S, Meyer M, Penque D, Cutting GR, Amaral MD. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am J Respir Cell Mol Biol. 2002;27:619–627. - PubMed

Publication types

MeSH terms

Substances